{"id":"W2589050849","doi":"10.1182/blood.v110.11.2579.2579","title":"First Report of a Phase II Clinical Trial of Lenalidomide Oral Therapy for Peripheral T-Cell Lymphoma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba; University of Ottawa; Dalhousie University; University of Calgary; University of Alberta","funders":"","keywords":"Lenalidomide; Medicine; Internal medicine; Rash; Thalidomide; Gastroenterology; Multiple myeloma; Chemotherapy regimen; Regimen; Neutropenia; Phases of clinical research; Clinical endpoint; Surgery; Chemotherapy; Oncology; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00370705,0.00182865,0.002193585,0.0003381338,0.0008124085,0.001148591,0.001387849,0.001937716,0.008118225],"category_scores_gemma":[0.001645206,0.00053431,0.0008958858,0.0003565722,0.0009384531,0.0006041566,0.0004268444,0.00333234,0.001774542],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001662125,"about_ca_system_score_gemma":0.004294926,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007333819,"about_ca_topic_score_gemma":0.01804282,"domain_scores_codex":[0.9991478,0.0003719992,0.00006028697,0.00009705076,0.0001499345,0.0001729914],"domain_scores_gemma":[0.9983735,0.0002460636,0.0001376238,0.00009809986,0.0001758444,0.0009689924],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5601935,0.05863455,0.0120658,0.002892679,0.003430035,0.001558116,0.0004487442,0.001654774,0.04263804,0.000650536,0.05676377,0.2590695],"study_design_scores_gemma":[0.641722,0.305313,0.0160409,0.0001506845,0.0008355455,0.0006159422,0.00004831026,0.00118172,0.005958447,0.000360405,0.0277305,0.00004260852],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8277726,0.02361181,0.007834189,0.009016898,0.002344132,0.06907423,0.02862863,0.0008897742,0.03082774],"genre_scores_gemma":[0.8929497,0.007757193,0.01180921,0.01244287,0.001479254,0.02184212,0.02966676,0.0001632091,0.02188962],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008118225,"threshold_uncertainty_score":0.02715814,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08000429015003754,"score_gpt":0.4267506636782165,"score_spread":0.3467463735281789,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}